Omeros (OMER) Change in Inventory (2015 - 2026)

Omeros (OMER) posted Change in Inventory of $183000.0 for Q1 2026, up 168.8% sequentially from -$266000.0 in Q3 2021.

Analysis

Omeros (OMER) Change in Inventory (2015 - 2026) Analysis & Trends

Omeros has reported Change in Inventory for 8 years, with the latest figure at $183000.0 in Q1 2026.

Quarterly Change in Inventory changed N/A year-over-year to $183000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$296000.0 (up 53.97% YoY) and the FY2020 annual result came in at $208000.0, down 80.36% from the prior year.
Change in Inventory climbed to $183000.0 in Q1 2026 per OMER's latest filing, from -$266000.0 in the prior quarter.
Over five years, Change in Inventory peaked at $183000.0 in Q1 2026 and troughed at $183000.0 in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	27.70 Mn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	28.20 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	132.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	47.15 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-280,000.00
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	12.97 Mn
10	Omeros	1.38 Bn	1.38 Bn	27.73 Mn	659,000.00

Historic Data

Download Data